Similar results have been obtained by Wang et al., who vaccinated GBM patients with personalized tumor-associated antigens (TAA)-pulsed DC combined with low-dose cyclophosphamide, poly I:C, Imiquimod, and anti-PD-1 antibody [174]. The gene discussed is PDCD1; the disease is neoplasm.